Patients with schizophrenia smoke at much higher prevalence rates (70-80%) than the general population (25 to 30%). This is true even when patients are identified in their first psychotic episodes, before they have been institutionalized or treated with antipsychotic medications.
|Original language||English (US)|
|Title of host publication||Nicotinic Receptors in the Nervous System|
|Number of pages||9|
|ISBN (Print)||084932386X, 9780849323867|
|State||Published - Jan 1 2001|
ASJC Scopus subject areas
- Pharmacology, Toxicology and Pharmaceutics(all)